TABLE 4.
Daily dietary energy, macronutrient, and micronutrient intakes of patients at baseline and after 3 months of intervention.
| Group | Before intervention | After intervention | Test value/p | p | |
|---|---|---|---|---|---|
| Median (min‐max) | Median (min‐max) | z | |||
| Energy (kcal) | Control group | 1677.85 (1253.80–1926.80) | 1715.55 (1565.70–1829.70) | −0.41 | .68 |
| MD | 1308.15 (1253.80–1800.20) | 1717.90 (1441.40–1937.50) | −1.58 | .11 | |
| GFD | 1610.65 (1315.10–1792.90) | 1713.20 (1614.30–1790.00) | −0.88 | .37 | |
| MGFD | 1753.05 (1441.40−1829.70) | 1812.30 (1591.40–1926.80) | −1.27 | .20 | |
| X 2 = 2.63 p = .45 | X 2 = 1.30 p = .73 | ||||
| Protein (%) | Control group | 20.00 (19.00–22.00) | 21.00 (19.00‐22.00) | −0.23 | .81 |
| MD | 17.00 (15.00–22.00) | 25.00 (22.00–26.00) | −2.67 | .01 | |
| GFD | 20.00 (16.00–22.00) | 20.00 (19.00–20.00) | −0.42 | .67 | |
| MGFD | 20.00 (19.00–21.00) | 19.50 (15.00–20.00) | −1.31 | .19 | |
| X 2 = 0.88 p = .83 | X 2 = 19.92 p = .00 Difference = 2 > 3.4 | ||||
| Carbohydrate (%) | Control group | 66.85 (63.50–81.80) | 81.30 (63.50–89.00) | −1.00 | .31 |
| MD | 60.40 (58.50–64.40) | 60.10 (24.60–70.50) | −0.66 | .51 | |
| GFD | 74.40 (64.40–79.00) | 83.60 (64.00–84.60) | −0.53 | .59 | |
| MGFD | 80.45 (60.10–90.00) | 85.40 (79.00–92.20) | −1.37 | .17 | |
| X 2 = 5.58 p = .13 | X 2 = 16.37 p = .00 difference = 2 < 3.4 | ||||
| Fat (%) | Control group | 39.50 (36.00‐44.00) | 39.00 (36.00–43.00) | −0.05 | .95 |
| MD | 41.00 (33.00–44.00) | 19.00 (16.00–31.00) | −2.80 | .01 | |
| GFD | 41.50 (38.00–46.00) | 42.00 (36.00–43.00) | −1.25 | .21 | |
| MGFD | 39.50 (33.00–43.00) | 39.00 (38.00–53.00) | −1.12 | .26 | |
| X 2 = 2.83 p = .42 | X 2 = 21.49 p = .00 Difference = 2 < 1.3.4 |
Abbreviations: GFD,Gluten‐free diet; MD, Mediterranean diet; MGFD, Mediterranean gluten‐free diet; X 2, Ki square, Krukal Wallis‐H; z,Wilcoxon test.